The Valley Desk

NCT00472693 · Interventional trial

Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer

Overall registry status Completed

Phase 2

Conditions Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov